Bridgebio Pharma (BBIO)'s 30-day implied volatility (IV30) was 46.6% at the close on November 17, 2026, up from 37.1% the day before, against a 52-week range of 33.5% to 82.4%. Its 20-day historical volatility was 37.1%.
Data as of November 17, 2026.